Erythropoietin: from erythropoiesis to cardioprotection
Many of the drugs that has shown promise in the treatment of hematologic malignancies and solid tumors, associated with a high potential cardiotoxic. Within this group stand anthracyclines, identified as the type of chemotherapy most likely to cause heart damage, short or long term. With the improve...
Saved in:
Main Authors: | Liermis Michael Dita Salabert (Author), Ivis Mendoza Hernández (Author), Rafael Alejandro Gómez Baute (Author), Elena García López (Author), Lázaro E. de la Cruz Avilés (Author), Aramis Núñez Quintana (Author) |
---|---|
Format: | Book |
Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos,
2010-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erythropoietin: from erythropoiesis to cardioprotection
by: Liermis Michael Dita Salabert, et al.
Published: (2010) -
Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
by: Rafael Alejandro Gómez Baute, et al.
Published: (2010) -
Recombinant human erythropoietin, and myocardial and cerebral acute ischemia: implications for clinical use.
by: Rafael Alejandro Gómez Baute, et al.
Published: (2010) -
Granuloma anular asociado a linfoma no Hodgkim difuso de células B grandes
by: Rafael Alejandro Gómez Baute, et al.
Published: (2011) -
Granuloma anular asociado a linfoma no Hodgkim difuso de células B grandes
by: Rafael Alejandro Gómez Baute, et al.
Published: (2011)